Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-27 5:07 pm Sale | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 23,709,102 16.900% | -5,013,153 (-17.45%) | View |
2023-08-14 5:01 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 28,722,255 26.580% | 1,348,863 (+4.93%) | View |
2022-10-20 4:01 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 27,373,392 25.420% | 1,904,121 (+7.48%) | View |
2022-07-20 4:00 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 25,469,271 28.400% | 1,187,562 (+4.89%) | View |
2022-06-15 4:31 pm Purchase | 13D | Silence Therapeutics plc SLN | Griffiths Richard Ian | 24,281,709 27.000% | 3,585,357 (+17.32%) | View |
2022-02-14 4:54 pm Sale | 13G | Silence Therapeutics plc SLN | Griffiths Richard Ian | 20,696,352 23.050% | -169,496 (-0.81%) | View |
2021-02-17 3:47 pm Purchase | 13G | Silence Therapeutics plc SLN | Griffiths Richard Ian | 20,865,848 23.300% | 20,865,848 (New Position) | View |